Zenflow
A minimally invasive implant system designed to relieve urinary symptoms caused by an enlarged prostate.
$52MSeries D
ParticipantC
ClavystBio
Activity from announced rounds
Activity in this selectionUnited States · Oct 23, 2026 · Jan 1, 2026
- Rounds participated in
- 2
- Confirmed lead rounds
- 0 1 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $77M 2 disclosed · full round size, not this investor’s share